This site is intended for healthcare professionals only
LoginRegister
Zydus Gets USFDA Approval for Generic Evoxac (Cevimeline) CapsulesZydus Lifscience Gets CDSCO Panel Nod To study Anti-cancer Drug Pertuzumab
CDSCO Clears AstraZenecas Imfinzi (Durvalumab) for Additional Cancer Indication in IndiaCDSCO panel approves AstraZeneca's Protocol Amendment proposal for Anticancer Drug AZD5305 study
Roche Vabysmo prefilled syringe approved in EU for three retinal conditions that can cause blindnessRoche Vabysmo prefilled syringe approved in EU for three retinal conditions that can cause blindness
Gilead Sciences gets USFDA nod for new Biktarvy indicationGilead Sciences Seladelpar gets positive CHMP opinion for Primary Biliary Cholangitis
Alembic buys UTI-focused Utility Therapeutics in USD 12 million dealAbbVie concludes acquisition of Aliada Therapeutics
Aurobindo Pharma Gets 11 USFDA Observations at Eugia UnitAurobindo Pharma Slapped With Rs 11 Crore GST Demand, Plans Appeal
Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIAIndian Pharma Market Posts Robust 10.7% Growth in November, Foracort Tops Sales: IQVIA
Bayer new drug application for gadoquatrane accepted for review in ChinaBayer acquires HiDoc Technologies, Cara Care app for irritable bowel syndrome
Aurobindo Pharmas Eugia Unit-I Gets 4 USFDA ObservationsAurobindo Pharma arm gets positive opinion from EMA Committee for Zefylti for neutropenia treatment
lupin acquires 3 anti diabetes trademarksLupin buys 3 anti-diabetes trademarks from Boehringer Ingelheim
Eli Lilly to acquire SiteOne Therapeutics in USD 1 billion dealELi Lilly Omvoh recommended by CHMP for approval in EU for adults with moderately to severely active...
DCGI Pushes Fast-Track Approval for Rare Disease Drugs, Prioritizes Patient AccessDCGI Pushes Fast-Track Approval for Rare Disease Drugs, Prioritizes Patient Access
X